40 results on '"Mwai, Kennedy"'
Search Results
2. Serum immunoglobulin G and mucosal immunoglobulin A antibodies from prepandemic samples collected in Kilifi, Kenya, neutralize SARS-CoV-2 in vitro
3. Malaria attributable fractions with changing transmission intensity: Bayesian latent class vs logistic models
4. Phagocytosis of Plasmodium falciparum ring-stage parasites predicts protection against malaria
5. Distinct kinetics of antibodies to 111 Plasmodium falciparum proteins identifies markers of recent malaria exposure
6. Characterization of Anopheles gambiae D7 salivary proteins as markers of human–mosquito bite contact
7. Comparative performance of WANTAI ELISA for total immunoglobulin to receptor binding protein and an ELISA for IgG to spike protein in detecting SARS-CoV-2 antibodies in Kenyan populations
8. Full-length MSP1 is a major target of protective immunity after controlled human malaria infection
9. Breadth of Fc-mediated effector function correlates with clinical immunity following human malaria challenge
10. protGear: A protein microarray data pre-processing suite
11. Age-dependent acquisition of IgG antibodies to Shigella serotypes—a retrospective analysis of seroprevalence in Kenyan children with implications for infant vaccination
12. Seven-year kinetics of RTS, S/AS01-induced anti-CSP antibodies in young Kenyan children
13. Bi-isotype immunoglobulins enhance antibody-mediated neutrophil activity against Plasmodium falciparum parasites.
14. Kinetics of naturally induced binding and neutralising anti-SARS-CoV-2 antibody levels and potencies among SARS-CoV-2 infected Kenyans with diverse grades of COVID-19 severity: an observational study
15. Temporal trends of dengue seroprevalence among children in coastal Kenya, 1998-2018: a longitudinal cohort study
16. Characterization of a novel Plasmodium falciparum merozoite surface antigen and potential vaccine target
17. Kinetics of naturally induced binding and neutralizing anti-SARS-CoV-2 antibody levels and potencies among Kenyan patients with diverse grades of COVID-19 severity
18. Characterization of a novel Plasmodium falciparum merozoite surface antigen and potential vaccine target.
19. Additional file 5 of Characterization of Anopheles gambiae D7 salivary proteins as markers of human���mosquito bite contact
20. Additional file 2 of Characterization of Anopheles gambiae D7 salivary proteins as markers of human���mosquito bite contact
21. Additional file 4 of Characterization of Anopheles gambiae D7 salivary proteins as markers of human���mosquito bite contact
22. Additional file 3 of Characterization of Anopheles gambiae D7 salivary proteins as markers of human���mosquito bite contact
23. Additional file 6 of Characterization of Anopheles gambiae D7 salivary proteins as markers of human���mosquito bite contact
24. Characterization of Naturally Acquired Immunity to a Panel of Antigens Expressed in Mature P. falciparum Gametocytes
25. High-throughput profiling of natural acquired humoral immune response to a large panel of known and novel full length ectodomain P. falciparum merozoite vaccine candidates under reduced malaria transmission
26. Factors Influencing Disengagement from Violent Extremism A Case of Majengo-Pumwani Slum, Nairobi-Kenya
27. Anti-merozoite antibodies induce natural killer cell effector function and are associated with immunity against malaria.
28. Estimating Malaria Attributable Fractions With Changing Transmission Intensity: Bayesian Latent Class Vs Logistic Models
29. Hepcidin regulation in Kenyan children with severe malaria and non-typhoidal Salmonella bacteremia
30. Additional file 2 of Seven-year kinetics of RTS, S/AS01-induced anti-CSP antibodies in young Kenyan children
31. Additional file 1 of Seven-year kinetics of RTS, S/AS01-induced anti-CSP antibodies in young Kenyan children
32. Referee report. For: ClinEpiDB: an open-access clinical epidemiology database resource encouraging online exploration of complex studies [version 1; peer review: 1 approved]
33. Distinct kinetics in antibody responses to 111 Plasmodium falciparum antigens identifies novel serological markers of recent malaria exposure
34. Systematic Serological Diversity of a Putative Malaria Vaccine Candidate and Broad Protection
35. Age, Spatial, and Temporal Variations in Hospital Admissions with Malaria in Kilifi County, Kenya: A 25-Year Longitudinal Observational Study
36. Gametocyte carriage in an era of changing malaria epidemiology: A 19-year analysis of a malaria longitudinal cohort
37. KILchip v1.0: A Novel Plasmodium falciparum Merozoite Protein Microarray to Facilitate Malaria Vaccine Candidate Prioritization
38. Reproducible Statistics course for the future, from Stata to R
39. Hepcidin regulation in Kenyan children with severe malaria and non-typhoidal Salmonella bacteremia.
40. Characterization of Naturally Acquired Immunity to a Panel of Antigens Expressed in Mature P. falciparum Gametocytes.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.